Niostem Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.79M

  • Investors
  • 5

Niostem General Information

Description

Developer of hair regenerative technology designed to unlock the body's natural regeneration potential. The company's device reactivates physiological hair growth and stops hair loss by restoring the ability to regenerate hair, enabling individuals to prevent hair loss without the use of drugs or painful procedures.

Contact Information

Website
www.niostem.com
Formerly Known As
Mane Biotech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Care of Startplatz, 4th floor
  • In Mediapark 5
  • 50670 Cologne
  • Germany
Primary Industry
Therapeutic Devices
Other Industries
Application Software
Biotechnology
Vertical(s)
Corporate Office
  • Care of Startplatz, 4th floor
  • In Mediapark 5
  • 50670 Cologne
  • Germany

Niostem Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Niostem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Jul-2024 $1.79M Completed Generating Revenue
5. Product Crowdfunding 19-Feb-2024 Completed Generating Revenue
4. Early Stage VC 18-Jan-2022 Completed Generating Revenue
3. Grant 03-Apr-2020 Completed Generating Revenue
2. Accelerator/Incubator $99K Completed Generating Revenue
1. Accelerator/Incubator 25-Sep-2019 $99K $99K Completed Generating Revenue
To view Niostem’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Niostem Patents

Niostem Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102024112729-B3 Device for stimulating hair growth with multiplexer Active 07-May-2024
WO-2025233735-A1 Device for stimulating hair growth with multiplexer Pending 07-May-2024
US-D994896-S1 Hair growth stimulator Active 20-Oct-2022
DE-102020121715-A1 Device for stimulating hair growth Active 19-Aug-2020
DE-102020121715-B4 Device for stimulating hair growth Inactive 19-Aug-2020 A61N1/36031
To view Niostem’s complete patent history, request access »

Niostem Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Niostem Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cohors Fortuna Capital Venture Capital Minority
BVP (Brightlands Venture Partners) Venture Capital Minority
Bundesministerium für Wirtschaft und Klimaschutz Government
Entrepreneurs First Venture Capital Minority
STARTPLATZ Accelerator/Incubator
To view Niostem’s complete investors history, request access »

Niostem FAQs

  • When was Niostem founded?

    Niostem was founded in 2019.

  • Where is Niostem headquartered?

    Niostem is headquartered in Cologne, Germany.

  • What is the size of Niostem?

    Niostem has 12 total employees.

  • What industry is Niostem in?

    Niostem’s primary industry is Therapeutic Devices.

  • Is Niostem a private or public company?

    Niostem is a Private company.

  • What is Niostem’s current revenue?

    The current revenue for Niostem is .

  • How much funding has Niostem raised over time?

    Niostem has raised $3.81M.

  • Who are Niostem’s investors?

    Cohors Fortuna Capital, BVP (Brightlands Venture Partners), Bundesministerium für Wirtschaft und Klimaschutz, Entrepreneurs First, and STARTPLATZ have invested in Niostem.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process